Table 4.
Maternal outcomes in COVID-19 and control groups
| Maternal outcomes | COVID-19 group, n (%) total N = 723 | Control group, n (%) total N = 644 | OR (CI) | p value |
|---|---|---|---|---|
| None | 605 (83.7) | 496 (77) | 1.53 (1.16–2.00) | 0.002* |
| APH | 9 (1.2) | 8 (1.2) | 1.00 (0.38–2.61) | 1.00 |
| Primary PPH | 5 (0.7) | 5 (0.8) | 0.90 (0.26–3.08) | 1.00 |
| Preterm labor | 17 (2.4) | 21 (3.3) | 0.71 (0.37–1.37) | 0.39 |
| Preterm delivery | 33 (4.6) | 44 (6.8) | 0.65 (0.41–1.03) | 0.08 |
| Threatened miscarriage | 3 (0.4) | 9 (1.4) | 0.29 (0.8–1.09) | 0.078 |
| Missed, incomplete miscarriage | 24 (3.3) | 59 (9.2) | 0.34 (0.21–0.55) | <0.0001* |
| IUFD | 6 (0.8) | 6 (0.9) | 0.89 (0.29–2.77) | 1.00 |
| Cardiac disease | 2 (0.3) | 0 (0) | 4.47 (0.21–93.28) | 0.50 |
| Preeclampsia | 12 (1.7) | 9 (1.4) | 1.19 (0.49–2.85) | 0.83 |
| Gestational HTN | 4 (0.6) | 1 (0.2) | 3.58 (0.39–32.11) | 0.38 |
| Respiratory | 9 (1.2) | 1 (0.2) | 8.11 (1.02–64.18) | 0.02* |
| MOF | 2 (0.3) | 0 (0) | 4.46 (0.21–93.28) | 0.50 |
| Sepsis | 1 (0.1) | 0 (0) | 2.68 (0.11–65.86) | 1.00 |
| VTE | 1 (0.1) | 0 (0) | 2.67 (0.11–65.86) | 1.00 |
| ICU admission | 12 (1.7) | 2 (0.3) | 22.65 (1.34–38.5) | 0.0006* |
| Maternal death | 0 (0) | 0 (0) | – | – |
| Others | 8 (1.1) | 5 (0.8) | 1.43 (0.47–4.39) | 0.59 |
APH, antepartum hemorrhage; PPH, postpartum hemorrhage; IUFD, intrauterine fetal death; MOF, multi-organ failure; VTE, venous thromboembolism; ICU, intensive care unit. *Statistically significant.